AU566013B2 - N-aryl-n:-(2-imidazolidinylidene)-urea compositions - Google Patents

N-aryl-n:-(2-imidazolidinylidene)-urea compositions

Info

Publication number
AU566013B2
AU566013B2 AU16400/83A AU1640083A AU566013B2 AU 566013 B2 AU566013 B2 AU 566013B2 AU 16400/83 A AU16400/83 A AU 16400/83A AU 1640083 A AU1640083 A AU 1640083A AU 566013 B2 AU566013 B2 AU 566013B2
Authority
AU
Australia
Prior art keywords
imidazolidinylidene
aryl
urea compositions
urea
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU16400/83A
Other versions
AU1640083A (en
Inventor
Chris Royce Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US05/972,580 priority Critical patent/US4239768A/en
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of AU1640083A publication Critical patent/AU1640083A/en
Application granted granted Critical
Publication of AU566013B2 publication Critical patent/AU566013B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16400/83A 1978-12-22 1983-06-29 N-aryl-n:-(2-imidazolidinylidene)-urea compositions Expired - Fee Related AU566013B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US972579 1978-12-22
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms
US972580 1997-11-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU53780/79A Division AU532332B2 (en) 1978-12-22 1979-12-13 N-phenyl-n:-(2-imidazolidinylidene) urea derivatives

Publications (2)

Publication Number Publication Date
AU1640083A AU1640083A (en) 1983-11-17
AU566013B2 true AU566013B2 (en) 1987-10-08

Family

ID=27130555

Family Applications (2)

Application Number Title Priority Date Filing Date
AU53780/79A Ceased AU532332B2 (en) 1978-12-22 1979-12-13 N-phenyl-n:-(2-imidazolidinylidene) urea derivatives
AU16400/83A Expired - Fee Related AU566013B2 (en) 1978-12-22 1983-06-29 N-aryl-n:-(2-imidazolidinylidene)-urea compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU53780/79A Ceased AU532332B2 (en) 1978-12-22 1979-12-13 N-phenyl-n:-(2-imidazolidinylidene) urea derivatives

Country Status (23)

Country Link
AT (1) AT373878B (en)
AU (2) AU532332B2 (en)
CA (1) CA1127651A (en)
CH (1) CH647236A5 (en)
DE (1) DE2951213A1 (en)
DK (1) DK548179A (en)
ES (1) ES8101558A1 (en)
FI (1) FI66354C (en)
FR (2) FR2444462B1 (en)
GB (2) GB2040681B (en)
GR (1) GR68018B (en)
HU (1) HU183013B (en)
IL (1) IL59019A (en)
IT (1) IT1126839B (en)
NL (1) NL7909265A (en)
NO (1) NO794249L (en)
NZ (1) NZ192453A (en)
PH (1) PH16571A (en)
PT (1) PT70624A (en)
SE (1) SE7910612L (en)
SU (1) SU971098A3 (en)
YU (1) YU314979A (en)
ZW (1) ZW25379A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (en) * 1960-08-05 1962-06-22 Geigy Ag J R New 2-imino-1.3-di-aza compounds and their preparation
NL267923A (en) * 1960-08-05

Also Published As

Publication number Publication date
FR2444462B1 (en) 1986-08-29
FR2444462A1 (en) 1980-07-18
FR2445321B1 (en) 1983-08-26
CA1127651A (en) 1982-07-13
AT373878B (en) 1984-02-27
GB2040681B (en) 1983-04-13
DK548179A (en) 1980-06-23
ES487159A0 (en) 1980-12-16
NL7909265A (en) 1980-06-24
GB2113204B (en) 1984-02-01
PH16571A (en) 1983-11-18
GB2113204A (en) 1983-08-03
IL59019A0 (en) 1980-03-31
DE2951213A1 (en) 1980-07-10
GB2040681A (en) 1980-09-03
FI66354B (en) 1984-06-29
IT7951164A0 (en) 1979-12-21
AU1640083A (en) 1983-11-17
YU314979A (en) 1983-02-28
AU5378079A (en) 1980-06-26
IL59019A (en) 1984-05-31
SU971098A3 (en) 1982-10-30
HU183013B (en) 1984-04-28
SE7910612L (en) 1980-06-23
ZW25379A1 (en) 1981-07-22
FI794036A (en) 1980-06-23
NO794249L (en) 1980-06-24
FI66354C (en) 1984-10-10
ATA808979A (en) 1983-07-15
FR2445321A1 (en) 1980-07-25
NZ192453A (en) 1982-09-07
CH647236A5 (en) 1985-01-15
PT70624A (en) 1980-01-01
AU532332B2 (en) 1983-09-29
IT1126839B (en) 1986-05-21
GR68018B (en) 1981-10-27
ES8101558A1 (en) 1980-12-16

Similar Documents

Publication Publication Date Title
AU528892B2 (en) Polymer-polyol compositions
AU4344579A (en) Nitro-bromo-alkanol compositions
AU525958B2 (en) Brush
AU4872779A (en) Defoamer compositions
AU526879B2 (en) N-methyl/n-phenyl-carbamate pesticidal compositions
AU523448B2 (en) Oral compositions
AU527553B2 (en) Radiopharmaceutical compositions
GB2026867B (en) Algicidal compositions
AU4356879A (en) Anti-collapsing chain
AU4559679A (en) Anti-ulcer composition
HK80984A (en) Etomidate-containing compositions
AU528625B2 (en) Pesticidal compositions
AU533616B2 (en) Polymeric compositions
AU4612879A (en) Disinfecting composition
PT69935A (en) Insecticidals compositions
AU530738B2 (en) Fasciolicidal compositions
AU566013B2 (en) N-aryl-n:-(2-imidazolidinylidene)-urea compositions
PT69225A (en) Compositions
PT70100A (en) Farmaceutical compositions
PT69656A (en) Benzylpyrimidine compositions
AU527901B2 (en) Organotin-pyrethroid pesticidal compositions
AU5277579A (en) Brush
AU516996B2 (en) Pesticidal compositions
AU524815B2 (en) Cleaning compositions
AU524292B2 (en) Pesticidal composition